Additional Proxy Soliciting Materials - Form DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement

☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐	Definitive Proxy Statement

☐	Definitive Additional Materials

☒	Soliciting Material under §240.14a-12

Clearwater Analytics Holdings, Inc.

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒	No fee required.

☐	Fee paid previously with preliminary materials.

☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

The following is an excerpt of a portion of the transcript of the earnings conference call held by Clearwater Analytics Holdings, Inc. (the "Company") on November 6, 2024, after market close:

Jim Cox:

I'd like to quickly discuss our Q3 results, provide Q4 guidance and then spend the majority of my time sharing our perspective on the proposal we will be providing to shareholders to terminate our Tax Receivable Agreement or what we call the TRA agreement.

…

Today along with these stellar third quarter results, we are announcing that we have filed an 8-K and related proxy statement related to the Tax Receivable Agreement between the company and our pre-IPO shareholders.

In the proxy statement, we are asking our unaffiliated stockholders to vote on a proposal to terminate the Tax Receivable Agreement by paying an aggregate of $72.5 million to the TRA counterparties and certain pre-IPO members of management.

We will only terminate the agreement if a majority of the company's unaffiliated stockholders, a group that excludes all parties to the TRA and all TRA bonus holders who we refer to as TRA participants as well as all named executive officers and those of our directors who are affiliated with the TRA participants, vote to approve the termination.

Said another way, we will not terminate the TRA unless a majority of the company's unaffiliated stockholders vote to approve the termination.

The proxy statement has additional details and we'll encourage you to review it, but I'd like to underscore why the Board and management believe the termination of the TRA is in the best interest of all shareholders. Let me start with some background.

In connection with our IPO, the company entered into a TRA, which provides for the payment by our public holding company to the TRA participants of 85% of the amount of any tax benefits that the company realizes or in some cases, is deemed to realize as a result of certain tax attributes.

One of those attributes is any increase in the tax basis of the net assets of CWAN Holdings, which is our less than wholly owned subsidiary that result from exchanges of CWAN Holdings units that TRA participants make for shares of Class A common stock in our public holding company.

In 2022, we recorded TRA expense of $11.6 million.

In 2023, we recorded TRA expense of $14.4 million. Through the first nine months of 2024, we have recorded $11.5 million of TRA expense and expect the full year TRA expense to be approximately $17 million absent any settlement.

We have not yet paid to the TRA participants the TRA expense owed to them for 2023 or year-to-date in 2024, and as of September 30, 2024, we have liabilities of $28.8 million recorded on our balance sheet related to the TRA liabilities incurred in the past.

While the amount and timing of future TRA payment obligations is inherently uncertain and is dependent upon the amount and timing of future taxable income and our share price, among other things, we estimate the potential sum of future TRA liability from past exchanges and hypothetical future exchanges as of September 30, 2024, to be $614 million, of which $417 million relates to historical exchanges, and $197 million is related to future exchanges at the company's share price as if exchanged on September 30, 2024.

In contrast, if termination of the TRA is approved by a majority of the company's unaffiliated stockholders.

The company will settle all TRA liabilities, the unpaid $28.8 million on the books as of September 30 and all future estimated TRA obligations for a total of $72.5 million.

We believe this transaction will have a number of benefits for the company.

First, it will generate significant savings compared to the cumulative expenses we expect we will incur over the life of the TRA.

Second, once terminated, the company will not have to utilize cash to fund ongoing TRA obligations. This will positively impact the company's future operating cash flow and potentially the company's valuation to the extent the company is valued based on cash flows.

Finally, terminating the TRA will eliminate the need to record a large liability when, or if, the company were to release the valuation allowance we currently maintain on our deferred tax asset balances.

By eliminating the potential to record the liability, we believe the company has greater ability to complete strategic transactions and provide shareholders greater certainty about the company's future financial performance. The payments made to TRA participants are not conditioned upon those TRA participants continuing to hold any ownership interest in CWAN Holdings or in the public company. Given the company's current strong cash position and the fact that certain of the TRA participants remain significant shareholders and hence, are aligned with the interests of other shareholders, which may change in the future, we believe now is the right time to terminate the tax receivable agreement.

For example, at the beginning of 2023, there were over 177 million Class C and Class D shares outstanding of the company's common stock, which were held exclusively by TRA participants.

That number reduced to approximately 115 million Class C and Class D shares outstanding at the end of 2023. And today, there are less than 75 million Class C and Class D shares outstanding.

For these reasons, we believe it is a good and shareholder-friendly use of resources to execute this TRA termination at this time.

We hope you agree, and we are all very happy that we are putting the ultimate decision whether to proceed or not to you, our shareholders. With that, I'll turn it over to Sandeep to provide some closing thoughts.

Sandeep Sahai:

I just wanted to thank the Clearwater team. These results were extraordinary, but they are not generated by Jim or myself or just Subi. It is the team which does that.

I also want to take a moment to thank the Board special committee, which did extraordinary work in bringing the TRA termination proposal to our shareholders for ratification on a vote.

******************

The following is an excerpt of a portion of the slides included in an investor presentation delivered by the Company on November 6, 2024, after market close:

Forward Looking Statements

This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or the Company's future financial or operating performance. In some cases, you can identify forward looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these words or other similar terms or expressions that concern the Company's expectations, strategy, priorities, plans or intentions. Forward-looking statements in this communication include, but are not limited to, statements relating to the timing of the effectiveness of the Amendment and the consummation of the TRA Buyout, statements relating to the expected benefits of the TRA Buyout and statements relating to the Company's expected performance in future periods. The Company's expectations and beliefs regarding these matters may not materialize, and actual results and events are subject to risks and uncertainties that could cause them to differ materially from those anticipated by the Company, including risks that the Company may not be able to satisfy the conditions to the effectiveness of the Amendment, including the requirement to obtain the approval of the Company's Unaffiliated Stockholders, risks related to the disruption of management's attention from the Company's ongoing business operations due to the TRA Buyout, risks related to the significant transaction costs to be paid in connection with the TRA Buyout and their impact on the Company's financial condition, risks of legal proceedings that may arise as a result of the TRA Buyout and changes in applicable laws or fluctuations in the Company's taxable income that could impact the Company's ability to realize the anticipated benefits from the TRA Buyout. The forward-looking statements contained in this communication are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission ("SEC"), including the Company's Annual Report on Form 10-K for the year ended December 31, 2023 filed on February 29, 2024, the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, the Proxy Statement (as defined below) and in other periodic reports the Company files with the SEC. The forward-looking statements in this communication are based on information available to the Company as of the date hereof, and the Company disclaims any obligation to update any forward-looking statements, except as required by law.

Additional Information and Where to Find It

In connection with the agreement to terminate its Tax Receivable Agreement (the "Amendment") and the TRA Buyout (as defined in the Proxy Statement), the Company filed a Proxy Statement on Schedule 14A (the "Proxy Statement") with the SEC on November 6, 2024 relating to a special meeting of its stockholders. This communication is not a substitute for the Proxy Statement or any other document that the Company may file with the SEC or send to its stockholders in connection with the Amendment and the TRA Buyout. THE COMPANY URGES YOU TO READ THE PROXY STATEMENT AND OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC CAREFULLY AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, THE AMENDMENT AND THE TRA BUYOUT AND RELATED MATTERS. Investors will be able to obtain a free copy of the Proxy Statement and other related documents (when available) filed by the Company with the SEC at the website maintained by the SEC at www.sec.gov. Investors also will be able to obtain a free copy of the Proxy Statement and other documents (when available) filed by the Company with the SEC by accessing the Investors section of the Company's website at https://investors.clearwateranalytics.com/overview/default.aspx.

Participants in the Solicitation

The Company and certain of its directors, executive officers and employees may be considered to be participants in the solicitation of proxies from the Company's stockholders in connection with the Amendment and the TRA Buyout. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the stockholders of the Company in connection with the TRA Buyout, including a description of their respective direct or indirect interests, by security holdings or otherwise, is set forth in the Proxy Statement. You may also find additional information about the Company's directors and executive officers in the Company's definitive proxy statement for its 2024 annual meeting of stockholders, which was filed with the SEC on April 29, 2024, or in

its Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on February 29, 2024, and in other documents filed by the Company with the SEC. You can obtain free copies of these documents from the Company using the contact information above.